TME Pharma NV (XPAR:ALTME) FCF Yield % : -80.82 (As of May. 15, 2024)

View and export this data going back to 2016. Start your Free Trial

What is TME Pharma NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, TME Pharma NV's Trailing 12-Month Free Cash Flow is €-5.65 Mil, and Market Cap is €7.00 Mil. Therefore, TME Pharma NV's FCF Yield % for today is -80.82%.

The historical rank and industry rank for TME Pharma NV's FCF Yield % or its related term are showing as below:

XPAR:ALTME' s FCF Yield % Range Over the Past 10 Years
Min: -238981.7 Med: -1172.09 Max: -25.12
Current: -80.82

During the past 10 years, the highest FCF Yield % of TME Pharma NV was -25.12%. The lowest was -238981.70%. And the median was -1172.09%.

XPAR:ALTME's FCF Yield % is ranked worse than
82.18% of 1554 companies
in the Biotechnology industry
Industry Median: -14.48 vs XPAR:ALTME: -80.82

TME Pharma NV's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

TME Pharma NV FCF Yield % Historical Data

The historical data trend for TME Pharma NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TME Pharma NV FCF Yield % Chart

TME Pharma NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-56.63

-19.88

-71.09

-580.00

-142.22

TME Pharma NV Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial													-74.07	-294.37	-600.50	-105.35	-112.74

Competitive Comparison of TME Pharma NV's FCF Yield %

For the Biotechnology subindustry, TME Pharma NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TME Pharma NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TME Pharma NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where TME Pharma NV's FCF Yield % falls into.

TME Pharma NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

TME Pharma NV's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-5.654	/	3.975504
	=	-142.22%

TME Pharma NV's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.241	*	2	/	3.975504
	=	-112.74%

TME Pharma NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

TME Pharma NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of TME Pharma NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

TME Pharma NV (XPAR:ALTME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (XPAR:ALTME) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

0N6A:Germany

Address

Max-Dohrn-Street 8-10, Berlin, DEU, 10589

Website

https://www.tmepharma.com

TME Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment and focusing on the improvement in the effectiveness of cancer therapies. Its product candidates are; NOX-A12 and NOX-E36 are based on a new class of drug first developed by TME Pharma called Spiegelmers, which offer specific advantages over other drug classes.

TME Pharma NV (XPAR:ALTME) Headlines

No Headlines